The treatment of glucocorticoid-induced osteoporosis.
Glucocorticoid use results in an increase risk for fractures. Over the past 10 years, we have a greater understanding of the epidemiology, pathophysiology, prevention and treatment of glucocorticoid induced osteoporosis. This article reviews these recent findings and selective practice guidelines.
Cohen
Dana
D
Adachi
Jonathan D
JD
D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005459:Fluorides / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects*; D020249:Hormone Replacement Therapy; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy* / Q000209:etiology; D014807:Vitamin D / Q000627:therapeutic use
D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D; D002116:Calcitonin; D005459:Fluorides; D002118:Calcium